Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Fibroblast glutamate transport in aging and in AD: correlations with disease severity

Zoia, C., Tagliabue, E., Isella, V., Begni, B., Fumagalli, L., Brighina, L., Appollonio, I. M., Racchi, M., & Ferrarese, C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.007 · Cited by 50

Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices

Rae, C. D., Lawrance, M. L., Dias, L. S., Provis, T., Bubb, W. A., & Balcar, V. J. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00372-5 · Cited by 50

Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways

Karki, P., Hong, P., Johnson, J., Pajarillo, E. A. B., Son, D., Aschner, M., & Lee, E.-S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0709-x · Cited by 49

Excitatory Amino Acid Transporter EAAT‐2 in Tangle‐bearing Neurons in Alzheimer's Disease

Thal, D. R. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00457.x · Cited by 49

Glutamate Receptor Genes

Schiffer, H. H. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:2:191 · Cited by 49

Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes

Brewer, G. J., Herrera, R. A., Philipp, S., Sosna, J., Reyes‐Ruiz, J. M., & Glabe, C. G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190835 · Cited by 47

Mechanisms of synaptic pathology in Alzheimer’s disease

Masliah, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_13 · Cited by 46

Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2

Kato, T., Kusakizako, T., Jin, C., Zhou, X., Ohgaki, R., Quan, L., Xu, M., Okuda, S., Kobayashi, K., Yamashita, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32442-6 · Cited by 47

The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis

Soares, C., Ros, L. U. D., Machado, L. S., da Rocha, A. S., Lazzarotto, G., Carello‐Collar, G., Bastiani, M. A. D., Ferrari‐Souza, J. P., Lussier, F. Z., Souza, D. O., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02473-0 · Cited by 50

Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory

Brothers, H. M., Bardou, I., Hopp, S. C., Kaercher, R. M., Corona, A. W., Fenn, A. M., Godbout, J. P., & Wenk, G. L. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9476-2 · Cited by 44

Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression

Audrain, M., Fol, R. R., Dutar, P., Potier, B., Billard, J., Flament, J., Alves, S., Burlot, M., Dufayet‐Chaffaud, G., Bemelmans, A., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0070-y · Cited by 44

Ciliary Neurotrophic Factor Protects Striatal Neurons against Excitotoxicity by Enhancing Glial Glutamate Uptake

Beurrier, C., Faideau, M., Bennouar, K.-E., Escartin, C., Goff, L. K., Bonvento, G., & Gubellini, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008550 · Cited by 43

Hippocampal Glutamate Level and Glutamate Aspartate Transporter (GLAST) are Up-Regulated in Senior Rat Associated with Isoflurane-Induced Spatial Learning/Memory Impairment

Qu, X., Xu, C., Wang, H., Xu, J., Liu, W., Wang, Y., Jia, X., Xie, Z., Xu, Z., Ji, C., et al. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0889-8 · Cited by 42

Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain

Azami Tameh, A., Clarner, T., Beyer, C., Atlasi, M. A., Hassanzadeh, G., & Naderian, H. (2013) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2013.03.004 · Cited by 43

Astrocyte in Neurological Disease: Pathogenesis and Therapy

Huang, M., Long, A., Hao, L., Shi, Z., & Zhang, M. (2025) · MedComm · doi:10.1002/mco2.70299 · Cited by 55

Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of Caenorhabditis elegans

Prasansuklab, A., Meemon, K., Sobhon, P., & Tencomnao, T. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2050-3 · Cited by 42

Stress and Alzheimer’s disease

Escher, C. M., Sannemann, L., & Jessen, F. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01988-z · Cited by 47

Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease

Guillemaud, O., Ceyzériat, K., Saint-Georges, T., Cambon, K., Petit, F., Haim, L. B., Sauvage, M.-A. C.-D., Guillermier, M., Bernier, S., Hérard, A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.010 · Cited by 40

Human Glioma Cells and Undifferentiated Primary Astrocytes That Express Aberrant EAAT2 mRNA Inhibit Normal EAAT2 Protein Expression and Prevent Cell Death

Guo, H. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1198 · Cited by 42

Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe/PS1dE9 mice

Lesuis, S. L., Kaplick, P. M., Lucassen, P. J., & Krugers, H. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.023 · Cited by 40

Towards the Discrimination of Carboxylates by Hydrogen‐Bond Donor Anion Receptors

Kadam, S. A., Martin, K., Haav, K., Toom, L., Mayeux, C., Pung, A., Gale, P. A., Hiscock, J. R., Brooks, S. J., Kirby, I. L., et al. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201405858 · Cited by 40

Amyloid β-peptide inhibits Na+-dependent glutamate uptake

Lauderback, C. M., Harris‐White, M. E., Wang, Y., Pedigo, N. W., Carney, J. M., & Butterfield, D. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00459-2 · Cited by 39

Astrocytes: The Stars in Neurodegeneration?

Dittlau, K. S., & Freude, K. (2024) · Biomolecules · doi:10.3390/biom14030289 · Cited by 39

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1–42 Oligomers

Wang, L.-S., Xue, T., Liu, X., Zhou, Y., Zhang, M.-D., Liao, Y., Pan, R., & Chang, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01084 · Cited by 38

Locally reduced levels of acidic FGF lead to decreased expression of 28‐kDa calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease

Thorns, V., Licastro, F., & Masliah, E. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00399.x · Cited by 38

Pharmacological models in Alzheimer's disease research

Gilles, C., & Ertle, S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/cgilles · Cited by 38

Oxidative stress impairs glutamate uptake in fibroblasts from patients with alzheimer's disease

Begni, B., Brighina, L., Sirtori, E., Fumagalli, L., Andreoni, S., Beretta, S., Oster, T., Malaplate, C., Isella, V., Appollonio, I. M., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.028 · Cited by 37

Differential Mechanisms in the Effects of Disulfiram and Diethyldithiocarbamate Intoxication on Striatal Release and Vesicular Transport of Glutamate

Vaccari, A., Ferraro, L., Saba, P., Ruiu, S., Mocci, I., Antonelli, T., & Tanganelli, S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37507-x · Cited by 37

Astrocytes in Neuropathologies Affecting the Frontal Cortex

Peteri, U., Niukkanen, M., & Castrén, M. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00044 · Cited by 38

Hippocampal alterations in glutamatergic signaling during amyloid progression in AβPP/PS1 mice

Hascup, K. N., Findley, C. A., Sime, L. N., & Hascup, E. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-71587-6 · Cited by 36

High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease

Nuzzo, T., Mancini, A., Miroballo, M., Casamassa, A., Maio, A. D., Donati, G., Sansone, G., Gaetani, L., Paoletti, F. P., Isidori, A. M., et al. (2021) · Amino Acids · doi:10.1007/s00726-021-02943-7 · Cited by 36

Substrate‐induced modulation of glutamate uptake in human platelets

Begni, B., Tremolizzo, L., D’Orlando, C., Bono, M. S., Garofolo, R., Longoni, M., & Ferrarese, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706242 · Cited by 36

Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease

Muñoz‐Ballester, C., Berthier, A., Viana, R., & Sanz, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.03.008 · Cited by 36

Role of Astrocytes in Manganese Neurotoxicity Revisited

Ke, T., Sidoryk‐Wȩgrzynowicz, M., Pajarillo, E. A. B., Rizor, A., Soares, F. A. A., Lee, E.-S., & Aschner, M. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02881-7 · Cited by 35

A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

Fontana, I. C., de Souza, D. G., Souza, D. O., Gee, A. D., Zimmer, E. R., & Bongarzone, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01572 · Cited by 37

Molecular Pharmacology of the Na+-Dependent Transport of Acidic Amino Acids in the Mammalian Central Nervous System.

Balcar, V. J. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.291 · Cited by 34

Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice

Mi, D. J., Dixit, S., Warner, T. A., Kennard, J. A., Scharf, D. A., Kessler, E. S., Moore, L. M., Consoli, D. C., Bown, C. W., Dukes, A. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.002 · Cited by 33

The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway

Naguib, S., Lopez-Lee, C., Torres, E. R., Lee, S.-I., Zhu, J., Zhu, D., Ye, P., Norman, K., Zhao, M., Wong, M. Y., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.05.023 · Cited by 32

Unravelling the glial response in the pathogenesis of Alzheimer's disease

Alibhai, J. D., Diack, A. B., & Manson, J. C. (2018) · The FASEB Journal · doi:10.1096/fj.201801360r · Cited by 31

Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease

Meeker, K. D., Meabon, J. S., & Cook, D. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142304 · Cited by 31

Uncovering Neurodegenerative Protein Modifications via Proteomic Profiling

Gallart‐Palau, X., Serra, A., & Sze, S. K. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.06.002 · Cited by 29

Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment

Wang, Z., Henn, B. C., Wang, C., Wei, Y., Su, L., Sun, R., Chen, H., Wagner, P. J., Lu, Q., Lin, X., et al. (2017) · Environmental Health · doi:10.1186/s12940-017-0288-3 · Cited by 31

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review

Song, B., & Zhu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.782457 · Cited by 31

Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review

Golmohammadi, M., Mahmoudian, M., Hasan, E. K., Alshahrani, S. H., Romero‐Parra, R. M., Malviya, J., Hjazi, A. M., Najm, M. A. A., Almulla, A. F., Zamanian, M. Y., et al. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12955 · Cited by 32

Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease

Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33

Aberrant expression of the pore-forming KATP channel subunit Kir6.2 in hippocampal reactive astrocytes in the 3xTg-AD mouse model and human Alzheimer’s disease

Griffith, C. M., Xie, M.-X., Qiu, W., Sharp, A. A., Ma, C., Pan, A., Yan, X., & Patrylo, P. R. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.034 · Cited by 33

Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)61007-5 · Cited by 31

Prolonged Inhibition of Glutamate Reuptake Down‐Regulates NMDA Receptor Functions in Cultured Cerebellar Granule Cells

Cebers, G., Cebere, A., Wägner, A., & Liljequist, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722181.x · Cited by 31

Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?

Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33

Nonanesthetic Effects of Ketamine: A Review Article

Eldufani, J., Nekoui, A., & Blaise, G. A. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.04.029 · Cited by 30

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review

Wood, O. W. G., Yeung, J. H. Y., Faull, R. L. M., & Kwakowsky, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.952096 · Cited by 33

From Molecular Circuit Dysfunction to Disease

Dulla, C. G., Coulter, D. A., & Žiburkus, J. (2015) · The Neuroscientist · doi:10.1177/1073858415585108 · Cited by 29

Symport and antiport mechanisms of human glutamate transporters

Qiu, B., & Boudker, O. (2023) · Nature Communications · doi:10.1038/s41467-023-38120-5 · Cited by 31

How do soluble oligomers of amyloid β-protein impair hippocampal synaptic plasticity?

Li, L. (2010) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2010.00005 · Cited by 33

Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus

Zhang, D., Mably, A. J., Walsh, D. M., & Rowan, M. J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw193 · Cited by 29

Evaluation of Drugs Acting at Glutamate Transporters in Organotypic Hippocampal Cultures: New Evidence on Substrates and Blockers in Excitotoxicity

O’Shea, R. D., Fodera, M. V., Apricó, K., Dehnes, Y., Danbolt, N. C., Crawford, D. J., & Beart, P. M. (2002) · Neurochemical Research · doi:10.1023/a:1014813518604 · Cited by 29

Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC ‐derived models of Alzheimer's disease

Salcedo, C., Garcia, V. P., García‐Adán, B., Ameen, A. O., Gegelashvili, G., Waagepetersen, H. S., Freude, K., & Aldana, B. I. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16014 · Cited by 30

Inflammatory Cytokine, IL-1β, Regulates Glial Glutamate Transporter via microRNA-181a in vitro

Zumkehr, J., Rodríguez‐Ortiz, C. J., Medeiros, R., & Kitazawa, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170828 · Cited by 28

Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses

Wu, J., Bie, B., Foss, J. F., & Naguib, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01885-7 · Cited by 28

Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 29

In the fast lane: Receptor trafficking during status epilepticus

Naylor, D. E. (2023) · Epilepsia Open · doi:10.1002/epi4.12718 · Cited by 27

Neurones express glutamine synthetase when deprived of glutamine or interaction with astrocytes

Fernandes, S. P., Dringen, R., Lawen, A., & Robinson, S. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06869.x · Cited by 27

Disruption of neuronal-glial-vascular units in the hippocampus of ovariectomized mice injected with d-galactose

Liu, L., Su, Y., Yang, W., Xiao, M., Gao, J., & Hu, G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.028 · Cited by 28

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

Sanz‐Blasco, S., Piña-Crespo, J., Zhang, X., McKercher, S. R., & Lipton, S. A. (2016) · Neuroreport · doi:10.1097/wnr.0000000000000601 · Cited by 28

Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1

Zoltowska, K. M., Maesako, M., Meier, J. C., & Berezovska, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-26888-2 · Cited by 27

Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death

Montoliu, C., Llansola, M., Monfort, P., Corbalán, R., Fernandez-Marticorena, I., Hernández-Viadel, M., & Felipo, V. (2001) · Neurotoxicity Research · doi:10.1007/bf03033190 · Cited by 27

Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease

Kang, H. J., Yoon, W. J., Moon, G. J., Kim, D. Y., Sohn, S., Kwon, H. J., & Gwag, B. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.004 · Cited by 27

Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer’s disease: Mechanistic insights and potential therapies

Ghatak, S., Nakamura, T., & Lipton, S. A. (2023) · Frontiers in Neural Circuits · doi:10.3389/fncir.2023.1099467 · Cited by 26

Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer’s Disease

Song, J., Yang, X., Zhang, M., Wang, C., & Chen, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210595 · Cited by 25

Glutamatergic Neurotransmission in Aging and Neurodegenerative Diseases: A Potential Target to Improve Cognitive Impairment in Aging

Castillo-Vázquez, S. K., Massieu, L., Rincón-Heredia, R., la Torre, P. G.-D., Quiroz‐Baez, R., Gómez-Verján, J. C., & Rivero-Segura, N. A. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103039 · Cited by 28

Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter

Yatomi, Y., Tanaka, R., Shimura, H., Miyamoto, N., Yamashiro, K., Takanashi, M., Urabe, T., & Hattori, N. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.018 · Cited by 26

Genetics of essential tremor: From phenotype to genes, insights from both human and mouse studies

Schmouth, J.-F., Dion, P. A., & Rouleau, G. A. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.05.001 · Cited by 27

Astroglial contribution to tau-dependent neurodegeneration

Sidoryk‐Wȩgrzynowicz, M., & Strużyńska, L. (2019) · Biochemical Journal · doi:10.1042/bcj20190506 · Cited by 26

APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition

Naguib, S., Lopez-Lee, C., Torres, E. R., Lee, S.-I., Zhu, J., Zhu, D., Ye, P., Norman, K., Zhao, M., Wong, M. Y., et al. (2024) · doi:10.1101/2024.04.25.591140 · Cited by 25

Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer’s disease: a preclinical study in rTg4510 mice

Foster, J. B., Lashley, R., Zhao, F., Wang, X., Kung, N., Askwith, C. C., Lin, L., Shultis, M. W., Hodgetts, K. J., & Lin, C. G. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0530-z · Cited by 26

Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer’s Disease

Jarero-Basulto, J. J., Rivera-Cervantes, M. C., Gasca‐Martínez, D., García‐Sierra, F., Gasca-Martínez, Y., & Beas‐Zárate, C. (2020) · Pharmaceuticals · doi:10.3390/ph13120424 · Cited by 27

Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer’s Disease

Jia, Y., Wang, X., Chen, Y., Qiu, W., Ge, W., & Ma, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02356-3 · Cited by 25

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease

Yeung, J. H. Y., Palpagama, T. H., Wood, O. W. G., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702824 · Cited by 26

Astrocytic transporters in Alzheimer's disease

Ugbode, C., Hu, Y., Whalley, B., Peers, C., Rattray, M., & Dallas, M. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160505 · Cited by 25

βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer’s Disease

Audrain, M., Souchet, B., Alves, S., Fol, R. R., Viodé, A., Haddjeri-Hopkins, A., Tada, S., Orefice, N. S., Joséphine, C., Bemelmans, A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx260 · Cited by 25

Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice

Wang, Y., Li, Y., Zhao, R., Wu, B., Lanoha, B., Tong, Z., Peer, J., Liu, J., Xiong, H., Huang, Y., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.007 · Cited by 23

Protective effects of vitamin E against hypercholesterolemia-induced age-related diseases

Catalgol, B., & Özer, N. K. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0235-9 · Cited by 24

The expression of astroglial glutamate transporters in patients with focal cortical dysplasia: an immunohistochemical study

Ulu, M. O., Tanrıverdi, T., Öz, B., Biçeroğlu, H., İşler, C., Eraslan, B. Ş., Özkara, Ç., Özyurt, E., & Uzan, M. (2009) · Acta Neurochirurgica · doi:10.1007/s00701-009-0548-2 · Cited by 24

Lethal weapon: amyloid β-peptide, role in the oxidative stress and neurodegeneration of Alzheimer’s disease

Lahiri, D. K., & Greig, N. H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.002 · Cited by 26

Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains

Sasaki, K., Shimura, H., Itaya, M., Tanaka, R., Mori, H., Mizuno, Y., Kosik, K. S., Tanaka, S., & Hattori, N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.015 · Cited by 24

Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity

Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 23

[3H](2S,4R)‐4‐Methylglutamate: a novel ligand for the characterization of glutamate transporters

Apricó, K., Beart, P. M., Lawrence, A. J., Crawford, D. J., & O’Shea, R. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00337.x · Cited by 23

Neuronally Derived Soluble Abeta Evokes Cell-Wide Astrocytic Calcium Dysregulation in Absence of Amyloid Plaquesin Vivo

Kelly, P., Sanchez-Mico, M. V., Hou, S. S., Whiteman, S. T., Russ, A., Hudry, E., Arbel‐Ornath, M., Greenberg, S. M., & Bacskai, B. J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1988-22.2023 · Cited by 25

Effect of bFGF on neuronal damage induced by sequential treatment of amyloid β and excitatory amino acid in vitro and in vivo

Noshita, T., Murayama, N., Oka, T., Ogino, R., Nakamura, S., & Inoue, T. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.020 · Cited by 22

EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson’s Disease

Das, S., Mccloskey, K., Nepal, B., & Kortagere, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04644-0 · Cited by 22

GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice

Gao, J., Liu, L., Liu, C., Fan, S., Liu, L., Liu, S., Xian, X., & Li, W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.580772 · Cited by 21

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25

Concordance of Several Subcellular Interactions Initiates Alzheimer’s Dementia: Their Reversal Requires Combination Treatment

Fessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21

The role of glutamate in dementia

Kornbuber, J., & Wiltfang, J. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_24 · Cited by 21

Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-d-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo

Camacho‐Morales, A., Montiel, T., & Massieu, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.069 · Cited by 21

Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila

Kilian, J., Hsu, H.-W., Mata, K., Wolf, F. W., & Kitazawa, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.011 · Cited by 21

Late appearance of glutamate transporter defects in a murine model of ALS–parkinsonism dementia complex

WILSON, J., & SHAW, C. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.017 · Cited by 21

NMDARs in Alzheimer’s Disease: Between Synaptic and Extrasynaptic Membranes

Escamilla, S., Sáez‐Valero, J., & Cuchillo‐Ibáñez, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810220 · Cited by 22

Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease

Hernandez, P., Rackles, E., Albóniga, O. E., Martínez‐Lage, P., Camacho, E. N., Onaindía, A., Fernandez, M., Talamillo, A., & Falcón‐Pérez, J. M. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70043 · Cited by 20

The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

Alijanpour, S., Miryounesi, M., & Ghafouri‐Fard, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01091-5 · Cited by 20

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467